Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility

Biochemical and Biophysical Research Communications

Volumn 285, Issue 1, 2001, Pages 118-128

  Funasaka, Tatsuyoshi ^a   Haga, Arayo ^a   Raz, Avraham ^b   Nagase, Hisamitsu ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AMF; Cell motility; gp78; Metastasis; Tumor angiogenesis

Indexed keywords

ANGIOGENIC FACTOR; AUTOCRINE MOTILITY FACTOR; COLLAGEN TYPE 1; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MOTILITY; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; UMBILICAL VEIN;

EID: 0034798524     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5135     Document Type: Article

References (54)

1. What is the evidence that tumors are angiogenesis dependent?
2. Tumor anglogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
3. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool
4. Quantification of angiogenesis in solid human tumors: An international consensus on the methodology and criteria of evaluation
5. Evaluation of the balance between anglogenic and antiangiogenic circulating factor in patients with breast and gastrointestinal cancers
6. Different angiogenic pathways characterize superficial and invasive bladder cancer
7. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
8. Mechanisms of angiogenesis
9. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small-cell lung cancer
10. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
11. Tumor cell autocrine motility factor
12. Identification of B16-BF1 melanoma autocrine motility-like factor receptor
13. Purification of B16-BF1 melanoma autocrine motility factor and its receptor
14. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells
15. Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells
16. Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants
17. Regulation of melanoma cell motility by the lipoxygenase metabolite 12(S)-HETE
18. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor
19. Tumor cell autocrine motility factor is the neuroleukin/ phosphohexose isomerase polypeptide
20. The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein
21. Expression and secretion of neuroleukin/Phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells
22. Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein
23. The phagokinetic tracks of 3T3 cells
24. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices
25. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and FGF
26. Angiogenic factors
27. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies
28. Embryonic stem cell-derived cystic embryoid bodies from vascular channels: An in vitro model of blood vessel development
29. Activated macrophages induce vascular proliferation
30. Angiogenesis
31. Interleukin-8 as a macrophage-derived mediator of anglogenesis
32. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor
33. Inhibition of vascular endothelial cell growth factor-induced angiogenesis suppresses tumor growth in viva
34. Glioblastoma growth inhibited in viva by a dominant-negative Flk-1 mutant
35. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastro-intestinal, kidney, and breast cancer
36. Serum phosphohexose isomerase in cancer. II. As an index of tumor growth in metastatic carcinoma of the breast
37. Serum phosphohexose isomerase activities in patients with colorectal cancer
38. Laboratory aids to diagnosis - Enzymes
39. Autocrine motility factor and its receptor: Role in cell locomotion and metastasis
40. Multiple use of a signal transduction pathway in tumor cell invasion
41. Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha
42. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo
43. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
44. Inhibition of endothelial regeneration by type-β transforming growth factor from platelets
45. Inhibitory action of transforming growth factor β on endothelial cells
46. Vascular endothelial growth factor is induced response to transforming growth factor-β in fibroblastic and epithelial cells
47. Macrophages and angiogenesis
48. Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix
49. Modulation of transforming growth factor-β receptor levels on microvascular endothelial cells during in vitro angiogenesis
50. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis
51. Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation
52. Interleukin-6 stimulates motility of vascular endothelium
53. Identification of defensing1, defensin-2, and CAP37/ azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils
54. cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases